Showing results 1 to 20 of 24
next >
| Issue Date | Title | Author(s) |
| 2018 | Change over 12 months in HbA(1c), fasting plasma glucose and weight among patients with type 2 diabetes in 37 countries: DISCOVER | Fenici, P.; Bonnet, F.; Chen, H.; Cid-Ruzafa, J.; Gomes, M. B.; Hammar, N.; Ji, L.; Kennedy, K. F.; Khunti, K.; Kosiborod, M.; Pocock, S.; Rathmann, W.; Shestakova, M. V.; Shimomura, I.; Charbonnel, B. |
| 2018 | Change over 12 months in HbA(1c), fasting plasma glucose and weight among patients with type 2 diabetes in 37 countries: DISCOVER | Fenici, P.; Bonnet, F.; Chen, H.; Cid-Ruzafa, J.; Gomes, M. B.; Hammar, N.; Ji, L.; Kennedy, K. F.; Khunti, K.; Kosiborod, M.; Pocock, S.; Rathmann, W.; Shestakova, M. V.; Shimomura, I.; Charbonnel, B. |
| 2015 | DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases | Hammar, N.; Charbonnel, B.; Fenici, P.; Garcia-Alvarez, L.; Gomes, M. B.; Hashigami, K.; Hiller, J.; Ji, L.; Khunti, K.; Nicolucci, A.; Pocock, S.; Shestakova, M. V.; Shimomura, I.; Surmont, F. A.; Medina, J. |
| 2015 | DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases | Hammar, N.; Charbonnel, B.; Fenici, P.; Garcia-Alvarez, L.; Gomes, M. B.; Hashigami, K.; Hiller, J.; Ji, L.; Khunti, K.; Nicolucci, A.; Pocock, S.; Shestakova, M. V.; Shimomura, I.; Surmont, F. A.; Medina, J. |
| 2017 | Factors associated with the discontinuation of metformin therapy: results from 11,539 patients in the global DISCOVER study | Khunti, K.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Kosiborod, M.; Nicolucci, A.; Pocock, S.; Rathmann, W.; Shestakova, M. V.; Watada, H.; Shimomura, I.; Tang, F.; Ji, L. |
| 2017 | Factors associated with the discontinuation of metformin therapy: results from 11,539 patients in the global DISCOVER study | Khunti, K.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Kosiborod, M.; Nicolucci, A.; Pocock, S.; Rathmann, W.; Shestakova, M. V.; Watada, H.; Shimomura, I.; Tang, F.; Ji, L. |
| 2017 | Glycaemic control in 14,005 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study | Ji, L.; Nicolucci, A.; Arya, N.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Kosiborod, M.; Pocock, S.; Shestakova, M. V.; Watada, H.; Shimomura, I.; Tang, F.; Khunti, K. |
| 2017 | Glycaemic control in 14,005 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study | Ji, L.; Nicolucci, A.; Arya, N.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Kosiborod, M.; Pocock, S.; Shestakova, M. V.; Watada, H.; Shimomura, I.; Tang, F.; Khunti, K. |
| 2017 | Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study | Gomes, M. B.; Charbonnel, B.; Cid-Ruzafa, J.; Fenici, P.; Hammar, N.; Khunti, K.; Kosiborod, M.; Nicolucci, A.; Pocock, S.; Shestakova, M. V.; Watada, H.; Shimomura, I.; Tang, F.; Ji, L. |
| 2017 | Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study | Gomes, M. B.; Charbonnel, B.; Cid-Ruzafa, J.; Fenici, P.; Hammar, N.; Khunti, K.; Kosiborod, M.; Nicolucci, A.; Pocock, S.; Shestakova, M. V.; Watada, H.; Shimomura, I.; Tang, F.; Ji, L. |
| Sep-2020 | Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: insights from the DISCOVER study | Arnold, S. V.; Khunti, K.; Tang, F.; Gomes, M. B.; Ji, L.; Nicolucci, A.; Shestakova, M. V.; Watada, H.; Cooper, A.; Hammar, N.; Fenici, P.; Medina, J.; Kosiborod, M. |
| 2018 | Individualised HbA(1c) targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study | Khunti, K.; Chen, H.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Kennedy, K. F.; Pocock, S.; Shestakova, M. V.; Shimomura, I.; Surmont, F.; Ji, L. |
| 2018 | Individualised HbA(1c) targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study | Khunti, K.; Chen, H.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Kennedy, K. F.; Pocock, S.; Shestakova, M. V.; Shimomura, I.; Surmont, F.; Ji, L. |
| 2018 | Quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study | Nicolucci, A.; Gomes, M. B.; Khunti, K.; Kosiborod, M.; Pocock, S.; Rathmann, W.; Shestakova, M. V.; Shimomura, I.; Watada, H.; Chen, H.; Cid-Ruzafa, J.; Fenici, P.; Hammar, N.; Tang, F.; Ji, L. |
| 2018 | Quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study | Nicolucci, A.; Gomes, M. B.; Khunti, K.; Kosiborod, M.; Pocock, S.; Rathmann, W.; Shestakova, M. V.; Shimomura, I.; Watada, H.; Chen, H.; Cid-Ruzafa, J.; Fenici, P.; Hammar, N.; Tang, F.; Ji, L. |
| Nov-2020 | Relationship between country income, socioeconomic factors and control of cardiovascular disease risk factors in patients with type 2 Diabetes: insights from the global DISCOVER registry | Malik, A.; Chen, H.; Cooper, A.; Gomes, M.; Hejjaji, V; Ji, L.; Khunti, K.; Kosiborod, M.; Nicolucci, A.; Peri-Okonny, P.; Shestakova, M.; Tang, F.; Vora, J.; Watada, H.; Arnold, S. |
| 2016 | Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22,272 individuals | Nicolucci, A.; Charbonnel, B.; Gomes, M. B.; Khunti, K.; Kosiborod, M.; Pocock, S.; Shestakova, M. V.; Fenici, P.; Hammar, N.; Hashigami, K.; Hiller, J.; Lillie, M.; Macaraeg, G.; Medina, J.; Ji, L. |
| 2016 | Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22,272 individuals | Nicolucci, A.; Charbonnel, B.; Gomes, M. B.; Khunti, K.; Kosiborod, M.; Pocock, S.; Shestakova, M. V.; Fenici, P.; Hammar, N.; Hashigami, K.; Hiller, J.; Lillie, M.; Macaraeg, G.; Medina, J.; Ji, L. |
| 2018 | Temporal trends in the use of sodium-glucose cotransporter-2 inhibitors: the global DISCOVER study | Ji, L.; Chen, H.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Khunti, K.; Pocock, S.; Shestakova, M. V.; Shimomura, I.; Surmont, F.; Tangy, F.; Kosiborod, A. I. |
| 2018 | Temporal trends in the use of sodium-glucose cotransporter-2 inhibitors: the global DISCOVER study | Ji, L.; Chen, H.; Cid-Ruzafa, J.; Fenici, P.; Gomes, M. B.; Hammar, N.; Khunti, K.; Pocock, S.; Shestakova, M. V.; Shimomura, I.; Surmont, F.; Tangy, F.; Kosiborod, A. I. |
